July 14,2006
Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs
Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.
Next Article Previous Article
Recent News
- Finance Committee Advances Social Security, USTR, HHS Nominations
- Crapo Statement at Hearing on the Rising Cost of Health Care
- Crapo Statement at Executive Session to Consider Social Security, USTR, HHS Nominations
- Crapo Announces Finance Committee Staff Updates
- Crapo Announces Executive Session, Hearing on Rising Health Care Costs